Format

Send to

Choose Destination
Nutr Hosp. 2018 Sep 7;35(Spec No6):64-69. doi: 10.20960/nh.2291.

[Bioactive food compounds as adjuvants to breast cancer treatment: vitamin D and omega-3].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
. laura.bermejol@salud.madrid.org.

Abstract

in English, Spanish

INTRODUCTION:

breast cancer (BC) is the most commonly diagnosed tumor in women and it continues to be the leading cause of cancer death in women. Quality of life decreases significantly during treatment and in the survivors. There is growing evidence linking the intake of certain foods, or their bioactive compounds, with better prognosis of the disease or improvements in physiological parameters that can increase BC patients' quality of life. But there are hardly any reviews to clarify the scientific evidence.

OBJECTIVES:

gathering and summarizing the available evidence on the effectiveness of the dietary compounds use as coadjuvants for BC treatment.

METHOD:

literature search using Pubmed to identify and analyze bioactive compounds as coadjvants for BC treatment.

RESULTS:

all tested compounds showed antitumor effects in vitro. Vvitamin D decrease risk of bone fracture, and marine lipids may reduce bone resorption and inflammation.

CONCLUSION:

there are bioactive compounds with potential to improve the quality of life of women with BC. Vitamin D a marine lipids provide a solid quality scientific evidence. Despite this, more controlled clinical trials are required to establish a direct link between the use of these compounds and the tumor progression or patient survival.

PMID:
30351165
DOI:
10.20960/nh.2291
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Aran ediciones, S.L.
Loading ...
Support Center